May 30, 2017 / 12:20 PM / 2 months ago

BRIEF-Sobi says Kineret gets expanded approval in Canada

1 Min Read

May 30 (Reuters) - Swedish Orphan Biovitrum (Sobi)

* Says Kineret approved in Canada for the treatment of neonatal-onset multisystem inflammatory disease (nomid) Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below